Search

JM to manufacture regulatory starting materials for Sarepta Therapeutics

News: Johnson Matthey to manufacture regulatory starting materials for Sarepta Therapeutics’ RNA technology-based clinical and commercial programmes.

Gender Pay Gap Report 2019

JM posts reduction in Gender Pay Gap in third report

Anna Manz, CFO, to leave Johnson Matthey and join LSEG

Johnson Matthey achieves successful commissioning of largest China methanol plant

We've announced that China’s Ningxia Baofeng Energy Group has successfully started up the 6600 mtpd methanol plant at their 600 kta coal to olefins (CTO) complex near Yinchuan in Ningxia Province PRC using JM catalyst and process technology.